Scientific Advisory Board

Force Diagnostics' Scientific Advisory Board is comprised of leaders and medical experts in health prevention and control, cardiology, oncology, psychiatry, alcohol and addiction psychiatry, public health, preventive medicine, bioengineering and translational medicine. This exceptional group confers quarterly and meets annually to offer insights on rapid diagnostics and to guide the development of new rapid diagnostic testing. 


Samuel C. Dudley, M.D., Ph.D. 

Fred C. and Katherine B. Andersen Chair--Adult Cardiology, Professor and Chief of Cardiology at University of Minnesota--Twin Cities; and Professor and Director of the Lillehei Heart Institute at University of Minnesota--Twin Cities. 

Advises on cardiovascular medicine, biomarkers, diagnostics tests, and devices.


Thomas Kosten, MA, M.D.

Jay H. Waggoner Chair; Vice-Chair, Psychiatry for Research; Director, Division of Alcohol and Addiction Psychiatry; Professor, Psychiatry, Neuroscience, and Pharmacology; and Co-Director, Institute for Clinical & Translational Research, Baylor College of Medicine.  

Advises on the identification of substance abuse disorders (drugs/alcohol/nicotine).  


Rashid Bashir, BSEE, MSEE, Ph.D. 

Abel Bliss Professor, Electrical and Computer Engineering & Bioengineering, University of Illinois; and Co-Founder, VP Technology Development, BioVitesse, Inc.

Advises on microfluidics, multiplex In Vitro Devices, and applied technologies.


Graham Colditz, M.D., DrPH

Deputy Director of the Institute for Public Health; Niess-Gain Professor in the School of Medicine; Chief of the Division of Public Health Sciences in the Department of Surgery; Program Director of the Master of Population Health Sciences Degree Program; and the Associate Director of Prevention & Control at the Siteman Cancer Center, Washington University.

Advises on new cancer biomarkers, prevention, and epidemiology.